Address

Room 205, School of Pharmaceutical Science

Tel.

0431-85619715

Email

suxy@jlu.edu.cn

Education Background

1999/09–2004/06 Ph.D., Biochemistry and Molecular Biology,School of Pharmacitical Science, Jilin University

1993/09-1999/06 Bachelor, Clinical Medicine, Norman Bethune University of Medical Sciences

Work Experience

2009/09- Associate Professor & Master Supervisor, School of Pharmaceutical Science, Jilin University

2004/07–2009/08 Lecturer,School of Pharmaceutical Science,Jilin University

Courses

Protein engineering,Molecular engineering

Research Field

Biological therapy; Precision Therapy Drugs;Targeted drug

Scientific Research Achievements

1.Xingcheng Yi, MD, Yulai Zhou, Hanyu Zheng, Luoying Wang,Tong Xu,Cong Fu*, Xiaoyun Su*.Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics. Medicine.2021

2.Diao JD, Ma LX, Wu CJ, Liu XH, Su XY, Bi HY, Bao B, Yan HW, Shi L*, Yang YJ*.Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma.Sci Rep. 2021,11(1):3382.

3.Diao J, Su X, Cao L, Yang Y*, Liu Y*. MicroRNA 874 inhibits proliferation and invasion of pancreatic ductal adenocarcinoma cells by directly targeting paired box 6.Mol Med Rep, 2018,18(1):1188-1196.

4.Yi X, Su X*, Zhang Y, Xu T, Fu C*.Study on Pathological Mechanism of Pneumonia Infected by Coronavirus Based on Time-series Gene Co-expression Network Analysis.IEEE, 8th ICBCB, 2020.

5.patents for inventions Xiaoyun Su，The invention relates to human hepatitis B virus surface antibody, preparation method and application thereof，China, CN201410794959.7，2018 6.Awards Study on Adult stem cell/tissue engineering and the key technique ahead of industrialization. The First Grade Prize of Jilin Provincial Scientific and Technological Progress Award in 2006.